Oncoplatin-AQ-50mg Inj.
MRP: ₹328.00
Packaging
10Ml INJECTION
Composition
Cisplatin 50mg
Company
Sun Pharma
MRP: ₹328.00
Packaging
10Ml INJECTION
Composition
Cisplatin 50mg
Company
Sun Pharma
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Platinex-50mg Inj. | Khandelwal | ₹275.00 | Save ₹53.00 |
| Platikem-50mg Inj. | Alkem Labs | ₹288.00 | Save ₹40.00 |
| Cisteen-50mg Inj. | Miracauls | ₹310.00 | Save ₹18.00 |
| Platicis 50mg Inj. | Zydus Cadila | ₹316.20 | Save ₹11.80 |
| Cytoplatin 50 mg Injection | Cipla | ₹349.00 | — |
| Blastolem-50mg Inj. | Elder Pharma | ₹370.00 | — |
| Uniplatin 50mg Inj. | United Biotech | ₹522.00 | — |
Severe nausea and vomiting. Serious toxic effects on the kidneys, bone marrows and ears. Hypomagnesaemia, hypocalcaemia, hyperuricaemia. Peripheral neuropathies, papilloedema, optic neuritis, seizures. Ototoxicity (children) manifested as tinnitus, loss of hearing, deafness or vestibular toxicity. Potentially Fatal: Rarely, renal damage due to inadequate hydration during therapy. Very rarely life-threatening myelosuppression. Anaphylactoid reactions (rare) and cardiac abnormalities.
Synergistic with 5-fluorouracil and etoposide. Efficacy increased and toxicity reduced when combined with radioprotecting agent WR 2721. At doses ≤100 mg, cisplatin is an ideal drug to combine with other cytotoxic drugs; unlike other antineoplastic drugs, it causes little myelosuppression. Potentially Fatal: Potentiates nephrotoxicity with aminoglycosides. Increased toxicity when combined with other cytotoxic drugs.
Patients with severe renal or auditory disorder, known hypersensitivity, severe bone marrow suppression, peripheral neuropathy, pregnancy, lactation.
Cisplatin modifies cell cycle by interfering with DNA structure and function. Effects are most prominent during the S phase but cells are killed at all stages. Cisplatin synergises with other anticancer drugs e.g. fluorouracil. It has a narrow therapeutic margin and is highly toxic. Absorption: Well absorbed (intraperitoneal). Distribution: Concentrated in the liver, kidneys, large and small intestines; poor penetration into the CNS. Excretion: Urine. Elimination half-life: 25-49 min (initial), 58-73 hr (terminal).
Patients with renal or hepatic disorder, myelosuppression. Monitor renal, neurological and auditory function. Perform blood counts regularly. Maintain adequate hydration before and 24 hr after admin to minimise nephrotoxicity.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Gemer 0.5mg Tablet 10s | TAB | ₹25.00 |
| Rebose 25mg Tablet 10s | TAB | ₹57.00 |
| Trapic E Tablet 10s | TAB | ₹162.00 |
| AB Phylline Cap | CAP | ₹105.00 |
| Ab Phylline N Tablet 10s | TAB | ₹149.00 |
| Ab Phylline Syrup 100ml | SYRUP | ₹107.00 |
| AB Phylline-SR-200 Tab | TAB | ₹167.00 |
| Absenz Syrup | SYRUP | ₹430.50 |
| Abzorb B Cream | CREAM | ₹60.00 |
| Abzorb Dust Powder 100gm | POWDER | ₹108.00 |
| Abzorb Dust Powder 75gm | POWDER | ₹95.00 |
| Abzorb Soap 100gm | SOAP | ₹131.75 |
| Acamprol Tab 6s | TAB | ₹70.00 |
| Acelast 100mg Capsule 10S | CAP | ₹65.00 |
| Acelast Syrup 100ml | SYRUP | ₹62.50 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist